oral semaglutide and alcohol for Use Disorder: The Endpoint Problem Could GLP-1 medications help transform

A 15% deficit translates to roughly 0.5 to 0.7 kg of weight loss a week for most adults

Compounded tirzepatide vs FDA-approved: a complete visual comparison Understanding the visual differences between compounded and FDA-approved tirzepatide prevents unnecessary confusion

Self-funded employers, already navigating the complexities of healthcare costs, now face the challenge of incorporating this expensive but potentially life-changing medication into their plans

Pinch the skin at the injection site

Clinical evidence suggests that combined SGLT2i and GLP-1 RA therapy is additive in terms of lowering HbA1c levels, systolic blood pressure, and body weight